| 2020 | Ezetimibe ameliorates lipid accumulation during adipogenesis by regulating the AMPK-mTORC1 pathway | FASEB JOURNAL |
| 2020 | Dual roles of ULK1 (unc-51 like autophagy activating kinase 1) in cytoprotection against lipotoxicity | AUTOPHAGY |
| 2019 | Inactivation of Sirtuin2 protects mice from acetaminophen-induced liver injury: possibleinvolvement of ER stress and S6K2 activation
| BMB REPORTS |
| 2019 | Repositioning of niclosamide ethanolamine (NEN), an anthelmintic drug, for the treatment of lipotoxicity | FREE RADICAL BIOLOGY AND MEDICINE |
| 2019 | Implantable Vascularized Liver Chip for Cross‐Validation of Disease Treatment with Animal Model | ADVANCED FUNCTIONAL MATERIALS |
| 2018 | C1q/TNF-α--Related Protein 1 (CTRP1) Maintains Blood Pressure Under Dehydration Conditions
| CIRCULATION RESEARCH |
| 2016 | Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis | FREE RADICAL BIOLOGY AND MEDICINE |
| 2016 | p62/SQSTM1 is required for the protection against endoplasmic reticulum stress-induced apoptotic cell death | FREE RADICAL RESEARCH |
| 2015 | p62 prevents carbonyl cyanide m-chlorophenyl hydrazine (CCCP)-induced apoptotic cell death by activating Nrf2 | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS |
| 2015 | PF-4708671, a specific inhibitor of p70 ribosomal S6 kinase 1, activates Nrf2 by promoting p62-dependent autophagic degradation of Keap1 | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS |
| 2015 | Concerted action of p62 and Nrf2 protects cells from palmitic acid-induced lipotoxicity | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS |
| 2015 | Fenofibrate activates Nrf2 through p62-dependent Keap1 degradation | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS |
http://orcid.org/0000-0003-4551-4294
